智通财经APP获悉，开拓药业-B(09939)早盘涨超5%，截至发稿，涨5.54%，报4.38港元，成交额199.09万港元。
消息面上，开拓药业公告，其全资附属公司与上美股份(02145)订立化妆品领域附带排他条款的战略合作框架协议，双方将围绕开拓药业旗下美白祛斑功效性化妆品原料KT-939展开深度合作，协同推进原料与产品注册，加速其商业化落地，共同打造具有行业影响力的“地表最强国产美白剂”。
智通财经APP获悉，开拓药业-B(09939)早盘涨超5%，截至发稿，涨5.54%，报4.38港元，成交额199.09万港元。
消息面上，开拓药业公告，其全资附属公司与上美股份(02145)订立化妆品领域附带排他条款的战略合作框架协议，双方将围绕开拓药业旗下美白祛斑功效性化妆品原料KT-939展开深度合作，协同推进原料与产品注册，加速其商业化落地，共同打造具有行业影响力的“地表最强国产美白剂”。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.